360° SearchNetwork Hot Spots Trends Time Series

Unigene Laboratories

Type: Company

Name: Unigene Laboratories

First reported May 17 2013 - Updated May 17 2013 - 1 reports

8-K/A - UNIGENE LABORATORIES INC (0000352747) (Filer)

Document Format FilesSeq Description Document Type Size 1 FORM 8-K/A ugne20130517_8ka.htm 8-K/A 27002 2 EXHIBIT 99.1 ugne20130517_8kaex99-1.htm EX-99 191123 3 logo.jpg GRAPHIC 6194 Complete submission text file 0001437749-13-006350.txt 227867 ... [Published SEC - May 17 2013]

Entities: Unigene Laboratories, 8-k

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Form 8-K/A UNIGENE LABORATORIES For: May 14

StreetInsider.com - Form 8-K/A UNIGENE LABORATORIES For: May 14 ... [Published Street Insider - May 17 2013]

Entities: Unigene Laboratories, 8-k

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 UNIGENE LABORATORIES For: May 14 Filed by: Levy Richard N

StreetInsider.com - Form 4 UNIGENE LABORATORIES For: May 14 Filed by: Levy Richard N ... [Published Street Insider - May 16 2013]

Entities: Unigene Laboratories

First reported May 14 2013 - Updated May 15 2013 - 2 reports

Unigene Laboratories, Inc. (UGNE) Announces First Quarter 2013 Financial Results and Provides Corporate Update

Staying up-to-date has never been simpler. Sign up for the today! BOONTON, N.J., May 14, 2013 /PRNewswire/ -- (PINK: UGNE) today announced financial results for the first quarter ended March 31, 2013 and provided a corporate update on the Company's financial ... [Published BioSpace - May 15 2013]

Entities: Unigene Laboratories

First reported May 14 2013 - Updated May 14 2013 - 3 reports

Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update

/PRNewswire/ -- Unigene Laboratories, Inc. (PINK: UGNE) today announced financial results for the first quarter ended March 31, 2013 and provided a corporate update on the Company's financial status and strategic initiatives. Ashleigh Palmer, Unigene's ... [Published Bio-Medicine - May 14 2013]

Entities: Ashleigh Palmer, Nordic Bioscience, Unigene Laboratories, Calcitonin, Exclusive License

First reported May 09 2013 - Updated May 09 2013 - 2 reports

Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs

Agreement Provides Unigene with Immediate Capital Infusion, as Well as Potential Royalty and Milestone PaymentsBOONTON, NJ, USA I May 9, 2013 IUnigene Laboratories, Inc. (UGNE), a leader in the design and development of peptide-based therapeutics, today ... [Published PipelineReview - May 09 2013]

Entities: Nordic Bioscience, Peptide, Exclusive License

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Form 4 UNIGENE LABORATORIES For: May 01 Filed by: Tune Joel A.

StreetInsider.com - Form 4 UNIGENE LABORATORIES For: May 01 Filed by: Tune Joel A. ... [Published Street Insider - May 03 2013]

Entities: Unigene Laboratories

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Form 4 UNIGENE LABORATORIES For: May 01 Filed by: Odlaug Theron Edwin

StreetInsider.com - Form 4 UNIGENE LABORATORIES For: May 01 Filed by: Odlaug Theron Edwin ... [Published Street Insider - May 03 2013]

Entities: Unigene Laboratories

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Form 4 UNIGENE LABORATORIES For: May 01 Filed by: SABATINO THOMAS J JR

StreetInsider.com - Form 4 UNIGENE LABORATORIES For: May 01 Filed by: SABATINO THOMAS J JR ... [Published Street Insider - May 03 2013]

Entities: Unigene Laboratories

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Form 4 UNIGENE LABORATORIES For: May 01 Filed by: WYSZOMIERSKI JACK L

StreetInsider.com - Form 4 UNIGENE LABORATORIES For: May 01 Filed by: WYSZOMIERSKI JACK L ... [Published Street Insider - May 03 2013]

Entities: Unigene Laboratories

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Unigene Laboratories Inc. Files SEC Form D, Notice of Exempt. . .

Unigene Laboratories Inc. Files SEC Form D, Notice of Exempt Offering of Securities (Apr. 22, 2013)Medicinal Chemicals and Botanical ProductsNewsRx.comBy a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating ... [Published Equities.com - May 01 2013]

Entities: Unigene Laboratories, US Securities and Exchange Commission, Regulation D, Chemical

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Form 4 UNIGENE LABORATORIES For: Apr 25 Filed by: Levy Richard N

StreetInsider.com - Form 4 UNIGENE LABORATORIES For: Apr 25 Filed by: Levy Richard N ... [Published Street Insider - Apr 30 2013]

Entities: Unigene Laboratories

Quotes

...Ashleigh Palmer, Unigene's Chief Executive Officer, commented, "2013 has been extremely challenging for Unigene. The FDA advisory committee recommendation against calcitonin containing products, followed by an Article 9 sale of our Biotechnologies strategic business unit (SBU) assets to affiliates of Victory Park Capital (VPC), has had a materially negative impact on the Company."

Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update [Published Bio-Medicine - May 14 2013]

Dr. Nozer Mehta, Chief Scientific Officer for Unigene stated, "We have been extremely pleased with our collaboration with Nordic Bioscience. The synergy between the capabilities of our two companies has allowed us to progress very rapidly with this exciting program. By way of the original JDV, Nordic has been able to expedite its evaluation of the Unigene peptides and has successfully used its industry-leading know-how and experience to determine their efficacy using a variety of cell-based technologies and animal models."

Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprieta ... [Published PipelineReview - May 09 2013]

...offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. " Unigene Laboratories Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital"

Now Available: Unigene Laboratories, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliance ... [Published Live-PR.com - Apr 16 2013]

Palmer concluded, "I must again thank Victory Park Capital for its timely rescue and ongoing support. Nevertheless, the coming months will be extraordinarily challenging. Despite the catastrophic impact the EMA's recommendation has had on Unigene, we remain resolute and deeply committed to the multiple opportunities we believe exist for Unigene and its pipeline of novel therapeutic peptides and expanding portfolio of Peptelligence™ oral peptide drug delivery partnerships."

Unigene Announces Third Quarter 2012 Corporate Update [Published PR Newswire - Nov 20 2012]

More Content

sort by: Date \| Relevance
Form 8-K/A UNIGENE LABORATORIES For: May 14 [Published Street Insider - May 17 2013]
8-K/A - UNIGENE LABORATORIES INC (0000352747) (... [Published SEC - May 17 2013]
Form 4 UNIGENE LABORATORIES For: May 14 Filed b... [Published Street Insider - May 16 2013]
Unigene Laboratories, Inc. (UGNE) Announces Fir... [Published BioSpace - May 15 2013]
Unigene Laboratories, Inc. Announces First Quar... [Published BioSpace - May 14 2013]
Unigene Announces First Quarter 2013 Financial ... [Published Bio-Medicine - May 14 2013]
Unigene Announces First Quarter 2013 Financial ... [Published Street Insider - May 14 2013]
Unigene Announces First Quarter 2013 Financial ... [Published TickerTech.com - May 14 2013]
Unigene Announces First Quarter 2013 Financial ... [Published Financial Services - May 14 2013]
Unigene and Nordic Bioscience Enter Equity Tran... [Published PipelineReview - May 09 2013]
Equity Transfer, License Agreement with Nordic ... [Published Genetic Engineering News - May 09 2013]
Unigene and Nordic Bioscience Enter Equity Tran... [Published Sys-Con Canada - May 09 2013]
Unigene and Nordic Bioscience Enter Equity Tran... [Published NewsBlaze - May 09 2013]
Unigene and Nordic Bioscience Enter Equity Tran... [Published PR Newswire: Financial Services - May 09 2013]
Form 4 UNIGENE LABORATORIES For: May 01 Filed b... [Published Street Insider - May 03 2013]
Form 4 UNIGENE LABORATORIES For: May 01 Filed b... [Published Street Insider - May 03 2013]
Form 4 UNIGENE LABORATORIES For: May 01 Filed b... [Published Street Insider - May 03 2013]
Form 4 UNIGENE LABORATORIES For: May 01 Filed b... [Published Street Insider - May 03 2013]
Unigene Laboratories Inc. Files SEC Form D, Not... [Published Equities.com - May 01 2013]
8-K - UNIGENE LABORATORIES INC (0000352747) (Fi... [Published SEC Filings - May 01 2013]
Form 4 UNIGENE LABORATORIES For: Apr 25 Filed b... [Published Street Insider - Apr 30 2013]
Unigene Laboratories Inc. Files SEC Form SC 13D... [Published Equities.com - Apr 25 2013]
Victory Park Capital Completes Public Auction o... [Published BioSpace - Apr 18 2013]
UNIGENE LABORATORIES INC: Victory Park Capital ... [Published 4 Traders - Apr 17 2013]
Victory Park Capital Completes Public Auction o... [Published Yahoo! Finance - Apr 17 2013]
Victory Park Capital Completes Public Auction o... [Published TickerTech.com - Apr 17 2013]
Victory Park Capital Completes Public Auction o... [Published Financial Services - Apr 17 2013]
8-K - UNIGENE LABORATORIES INC (0000352747) (Fi... [Published SEC Filings - Apr 16 2013]
Now Available: Unigene Laboratories, Inc. - Mer... [Published Live-PR.com - Apr 16 2013]
8-K - UNIGENE LABORATORIES INC (0000352747) (Fi... [Published SEC Filings - Apr 12 2013]

Blogs

sort by: Date \| Relevance
A Hundred Jobs Here, A Hundred Jobs There: More... [Published Pharmalot - Apr 10 2013] As the pharmaceutical industry continues to contract, keeping track of the number of people thrown overboard is a challenging exercise, especially as the largest drugmakers eliminate jobs by the thousands in successive waves. Consequently, it can be ...

Press Releases

sort by: Date \| Relevance
Unigene Announces First Quarter 2013 Financial ... [Published Financial Services - May 14 2013]
Unigene and Nordic Bioscience Enter Equity Tran... [Published PR Newswire: Financial Services - May 09 2013]
Victory Park Capital Completes Public Auction o... [Published Financial Services - Apr 17 2013]
- Unigene Secures Financing to Extend Operating... [Published PR Newswire: Financial Services - Apr 08 2013]
Unigene Announces Fourth Quarter and Full-Year ... [Published Financial Services - Mar 11 2013]